Balentine LLC Stryker Corp Transaction History

Balentine LLC

$2.54 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$293.94 - $358.71 $34,978 - $42,686	119 Added 4.85%	2,571 $920,000
Q4 2023 Feb 09, 2024	BUY	$253.85 - $299.46 $16,754 - $19,764	66 Added 2.77%	2,452 $734,000
Q3 2023 Nov 13, 2023	SELL	$266.54 - $302.43 $8,262 - $9,375	-31 Reduced 1.28%	2,386 $652,000
Q2 2023 Aug 14, 2023	BUY	$271.49 - $305.09 $50,225 - $56,441	185 Added 8.29%	2,417 $737,000
Q1 2023 May 11, 2023	BUY	$246.13 - $285.47 $26,828 - $31,116	109 Added 5.13%	2,232 $637,000
Q4 2022 Jan 31, 2023	BUY	$205.51 - $253.93 $103,577 - $127,980	504 Added 31.13%	2,123 $519,000
Q3 2022 Oct 26, 2022	BUY	$189.27 - $231.83 $28,579 - $35,006	151 Added 10.29%	1,619 $328,000
Q2 2022 Oct 26, 2022	SELL	$194.09 - $276.37 $307,632 - $438,046	-1,585 Reduced 51.92%	1,468 $292,000
Q2 2022 Aug 15, 2022	BUY	$194.09 - $276.37 $284,924 - $405,711	1,468 New	1,468 $292,000
Q1 2022 Oct 26, 2022	BUY	$245.33 - $277.77 $388,848 - $440,265	1,585 Added 107.97%	3,053 $816,000
Q4 2021 Oct 26, 2022	SELL	$236.63 - $276.44 $41,883 - $48,929	-177 Reduced 12.06%	1,291 $345,000
Q4 2021 Feb 02, 2022	SELL	$236.63 - $276.44 $318,977 - $372,641	-1,348 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$248.9 - $280.09 $74,172 - $83,466	298 Added 28.38%	1,348 $355,000
Q2 2021 Aug 16, 2021	BUY	$242.95 - $267.0 $15,548 - $17,088	64 Added 6.49%	1,050 $273,000
Q1 2021 May 10, 2021	BUY	$221.01 - $248.82 $221 - $248	1 Added 0.1%	986 $240,000
Q4 2020 Feb 08, 2021	BUY	$202.01 - $245.04 $198,979 - $241,364	985 New	985 $241,000
Q3 2020 Nov 02, 2020	SELL	$177.77 - $215.81 $168,170 - $204,156	-946 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$144.67 - $207.03 $109,949 - $157,342	760 Added 408.6%	946 $170,000
Q1 2020 May 18, 2020	SELL	$126.5 - $225.1 $49,082 - $87,338	-388 Reduced 67.6%	186 $31,000
Q4 2019 Sep 02, 2020	BUY	$197.98 - $220.53 $77,410 - $86,227	391 Added 213.66%	574 $121,000
Q3 2019 Nov 15, 2019	BUY	$205.4 - $221.82 $5,545 - $5,989	27 Added 17.31%	183 $40,000
Q2 2019 Aug 14, 2019	BUY	$180.24 - $205.58 $7,570 - $8,634	42 Added 36.84%	156 $32,000
Q3 2018 Nov 14, 2018	BUY	$163.25 - $177.68 $18,610 - $20,255	114 New	114 $20,000
Q1 2018 May 16, 2018	SELL	$148.01 - $168.91 $65,124 - $74,320	-440 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$138.36 - $147.87 $60,878 - $65,062	440	440 $62,000

Others Institutions Holding SYK

# of Institutions

2,230

Shares Held

285M

Call Options Held

1.35M

Put Options Held

1.6M

Vanguard Group Inc Valley Forge, PA

32.4M
Shares

$12.6 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

26.8M
Shares

$10.4 Billion
0.21% of portfolio
Greenleaf Trust Kalamazoo, MI

18.5M
Shares

$7.22 Billion
59.81% of portfolio
State Street Corp Boston, MA

14.6M
Shares

$5.68 Billion
0.22% of portfolio
Price T Rowe Associates Inc Baltimore, MD

11.1M
Shares

$4.31 Billion
0.46% of portfolio

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $147B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account